BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37705005)

  • 1. The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients.
    Oglesby IK; Slattery D; Glynn N; Gupta S; Duggan K; Cuesta M; Dunne E; Garrahy A; Toner S; Kenny D; Agha A
    BMC Endocr Disord; 2023 Sep; 23(1):197. PubMed ID: 37705005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Edén Engström B; Ekman B; Norrving B; Hagmar L; Erfurth EM
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3560-7. PubMed ID: 17623762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
    Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
    Hána V; Prázný M; Marek J; Skrha J; Justová V
    Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.
    Nishizawa H; Iguchi G; Murawaki A; Fukuoka H; Hayashi Y; Kaji H; Yamamoto M; Suda K; Takahashi M; Seo Y; Yano Y; Kitazawa R; Kitazawa S; Koga M; Okimura Y; Chihara K; Takahashi Y
    Eur J Endocrinol; 2012 Jul; 167(1):67-74. PubMed ID: 22535644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
    Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
    Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
    Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
    Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
    Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
    Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.
    Davies JS; Obuobie K; Smith J; Rees DA; Furlong A; Davies N; Evans LM; Scanlon MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin.
    Smith JC; Lane HA; Lewis J; Dann S; Goodfellow J; Collins P; Evans LM; Scanlon MF; Davies JS
    J Clin Endocrinol Metab; 2003 May; 88(5):2152-6. PubMed ID: 12727969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.
    He X; Barkan AL
    Pituitary; 2020 Jun; 23(3):294-306. PubMed ID: 32060708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.